These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24615483

  • 1. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway.
    Mencej-Bedrač S, Zupan J, Mlakar SJ, Zavratnik A, Preželj J, Marc J.
    Drug Metabol Drug Interact; 2014; 29(2):111-4. PubMed ID: 24615483
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
    Mencej-Bedrac S, Prezelj J, Kocjan T, Teskac K, Ostanek B, Smelcer M, Marc J.
    J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.
    Tu P, Duan P, Zhang RS, Xu DB, Wang Y, Wu HP, Liu YH, Si L.
    Osteoporos Int; 2015 Jan; 26(1):179-85. PubMed ID: 25138264
    [Abstract] [Full Text] [Related]

  • 5. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM.
    Menopause; 2007 Jan; 14(5):913-8. PubMed ID: 17667143
    [Abstract] [Full Text] [Related]

  • 6. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
    Mencej S, Prezelj J, Kocijancic A, Ostanek B, Marc J.
    Maturitas; 2006 Oct 20; 55(3):219-26. PubMed ID: 16730419
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
    Mencej S, Albagha OM, Prezelj J, Kocjan T, Marc J.
    J Mol Endocrinol; 2008 Jun 20; 40(6):273-9. PubMed ID: 18502820
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S, Preželj J, Marc J.
    Maturitas; 2011 Jul 20; 69(3):263-7. PubMed ID: 21411255
    [Abstract] [Full Text] [Related]

  • 11. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
    Shang M, Lin L, Cui H.
    Clin Biochem; 2013 Oct 20; 46(15):1493-501. PubMed ID: 23531404
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.